Category: Nanomedicine
Europe Nanomedicine
-
Nanomedicine Market Research Report: Information by Modality (Treatments and Diagnostics), by Application (Drug Delivery, Diagnostic Imaging, Vaccines, Regenerative Medicine, and Implants), and by Indication (Oncological Diseases, Infectious Diseases, Cardiovascular Diseases, Orthopedic Diseases, Neurological Diseases, Urological Diseases, Ophthalmological Diseases, Immunological Diseases, and Others), by Molecule Type (Nanoparticles [Albumin Particles, Inorganic Nanoparticles, Lipid Nanoparticle, Liposomes, and Others], Nanoshells, Nanotubes, and Nanodevices), and by Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032
... Diseases, Ophthalmological Diseases, Immunological Diseases, and Others), by Molecule Type (Nanoparticles [Albumin Particles, Inorganic Nanoparticles, Lipid Nanoparticle, Liposomes, and Others], Nanoshells, Nanotubes, and Nanodevices), and by Region (North America, Europe, Asia-Pacific, and Rest of the ... Read More
-
Switzerland Artificial Blood Vessels Market Forecast 2024-2032
... of $86.56 million by 2032. MARKET INSIGHTS The artificial blood vessels market in Switzerland is witnessing significant growth, primarily amped by the increasing prevalence of aortic diseases. These conditions have become a catalyst for market ... Read More
-
Nanomedicine Therapeutics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2030, Segmented By Indication (Oncology, Infectious Disease, Cardiology, Neurological Disease); By Application (Drug Delivery, Regenerative Medicine, Vaccines, Active Implants); By Region (North America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa (MEA))
... America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa (MEA)) Global Nanomedicine Therapeutics Market Size Booming at CAGR of 9.42% to Surpass Whopping USD 369 Billion by 2030 Global Nanomedicine Therapeutics Market ... Read More
-
Europe Nanotechnology Drug Delivery Market Size, Share & Trends Analysis Report By Formulation (Polymer-Based Nanomedicine, Lipid-Based Nanomedicine, Nanocrystals, and Others), By Application, By Country and Growth Forecast, 2023 - 2030
... Market would witness market growth of 8.5% CAGR during the forecast period (2023-2030). In the realm of neurological drug delivery, nanotechnology has shown promise in treating conditions such as Alzheimer's disease, Parkinson's disease, and brain ... Read More
-
Lipid Nanoparticle Manufacturing Market: Services and Technologies, 2023-2035 - Distribution by Type of Lipid Nanoparticle (Solid Lipid Nanoparticles and Nanostructured Lipid Carriers), Type of Molecule Delivered (Nucleic Acids, Small Molecules, Proteins/Peptides and Others), Company Size (Very Large and Large, Mid-sized and Small), Target Therapeutic Area (Infectious Diseases, Oncological Disorders, Blood Disorders, Rare Diseases and Other Disorders), Type of End-user (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Other End-users) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts
... (Very Large and Large, Mid-sized and Small), Target Therapeutic Area (Infectious Diseases, Oncological Disorders, Blood Disorders, Rare Diseases and Other Disorders), Type of End-user (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Other End-users) ... Read More
-
Injectable Nanomedicines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global demand for injectable nanomedicines is witnessing significant growth, driven by advancements in nanotechnology that enhance drug safety and efficacy. These nanomedicines are designed to release drugs at targeted sites, allowing for the accumulation of ... Read More
-
Nanoparticle Contract Manufacturing (Focus on Lipid and Metal Nanoparticles) Market by Company Size (Very Small, Small, Mid-sized and Large), Type of Nanoparticle(s) Manufactured (Lipid and Metal Nanoparticles), Scale of Operation (Preclinical, Clinical and Commercial), Type of End User (Educational Institutions, Pharmaceutical Companies, Research Institutions, and Other End Users), and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, Latin America, and Rest of the World): Industry Trends and Global Forecasts, 2021-2035
... of End User (Educational Institutions, Pharmaceutical Companies, Research Institutions, and Other End Users), and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, Latin America, and Rest of the World): Industry Trends ... Read More
-
Spain Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibr
... GlobalData’s “Spain Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Spain Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
Italy Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... GlobalData’s “Italy Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Italy Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
EU5 Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroi
... GlobalData’s “EU5 Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the EU5 Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
France Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... GlobalData’s “France Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the France Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
United Kingdom (UK) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to trea
... 2030 Summary GlobalData’s “United Kingdom Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the United Kingdom Embolization Particle Procedures. The databook report provides procedure volumes within segments ... Read More
-
Bioactive Materials Market, By Material Type (Bioactive Glass, Bioactive Ceramics, Bioactive Composites, Other Material Types), By Application (Dental Care, Nanomedicines and Biotechnology, Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Bioactive materials have many different uses, including tissue engineering, regenerative medicine, diagnostics, and wound repair. They can also have applications in cancer therapy ... Read More
-
Biopharmaceutical and Biomedicine Market, by Product Type (Biopharmaceutical (Monoclonal Antibodies, Vaccines, Recombinant Human Insulin, Human Growth Hormone, Erythropoietin, Interferon, Colony Stimulating Factor, Blood Factors, Fusion Protein, and Others), Nanomedicine, Cell & Gene Therapy, Bioinformatics, and Molecular Enzymes & Kits), by Application (Therapeutics, Diagnostics, and Research and Development), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Molecular Enzymes & Kits), by Application (Therapeutics, Diagnostics, and Research and Development), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
-
Nanomedicines Market, By Application (Cardiovascular, Anti-inflammatories, Anti-infectives, Neurology, Oncology, Others (dental, orthopedic, urology, ophthalmic)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) -
... 2022 - 2028 Nanomedicine products have applications in drug delivery, in vivo imaging, in vitro diagnostics, regenerative medicine, dental, medical devices, and dermal applications. Major drivers for the global nanomedicine market constitutes of increasing government ... Read More
Research Assistance
